Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/06/17
End: 01/10/19
Due: 01/10/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma | NCT03349255 | Aeon Therapeutics (Shanghai) Co., Ltd. | user2@example.com | None | 2017-10-06 | 2019-01-10 | 2020-01-10 | - | - | 2025-07-14 |